These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
460 related articles for article (PubMed ID: 19607756)
21. Effects of fatty acid amide hydrolase inhibitor URB597 in a rat model of trauma-induced long-term anxiety. Danandeh A; Vozella V; Lim J; Oveisi F; Ramirez GL; Mears D; Wynn G; Piomelli D Psychopharmacology (Berl); 2018 Nov; 235(11):3211-3221. PubMed ID: 30251159 [TBL] [Abstract][Full Text] [Related]
22. Effects of the cannabinoid CB1 receptor agonist CP55,940 and antagonist SR141716A on d-amphetamine-induced behaviours in Cebus monkeys. Madsen MV; Peacock L; Werge T; Andersen MB J Psychopharmacol; 2006 Sep; 20(5):622-8. PubMed ID: 16533866 [TBL] [Abstract][Full Text] [Related]
23. Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia. Vigano D; Guidali C; Petrosino S; Realini N; Rubino T; Di Marzo V; Parolaro D Int J Neuropsychopharmacol; 2009 Jun; 12(5):599-614. PubMed ID: 18789179 [TBL] [Abstract][Full Text] [Related]
24. Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats. Forget B; Guranda M; Gamaleddin I; Goldberg SR; Le Foll B Psychopharmacology (Berl); 2016 May; 233(10):1823-8. PubMed ID: 26864774 [TBL] [Abstract][Full Text] [Related]
25. Local enhancement of cannabinoid CB1 receptor signalling in the dorsal hippocampus elicits an antidepressant-like effect. McLaughlin RJ; Hill MN; Morrish AC; Gorzalka BB Behav Pharmacol; 2007 Sep; 18(5-6):431-8. PubMed ID: 17762511 [TBL] [Abstract][Full Text] [Related]
26. Inhibitors of endocannabinoid-metabolizing enzymes reduce precipitated withdrawal responses in THC-dependent mice. Schlosburg JE; Carlson BL; Ramesh D; Abdullah RA; Long JZ; Cravatt BF; Lichtman AH AAPS J; 2009 Jun; 11(2):342-52. PubMed ID: 19430909 [TBL] [Abstract][Full Text] [Related]
27. Endocannabinoid modulation of male rat sexual behavior. Gorzalka BB; Morrish AC; Hill MN Psychopharmacology (Berl); 2008 Jul; 198(4):479-86. PubMed ID: 17694389 [TBL] [Abstract][Full Text] [Related]
28. Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. Hill MN; McLaughlin RJ; Morrish AC; Viau V; Floresco SB; Hillard CJ; Gorzalka BB Neuropsychopharmacology; 2009 Dec; 34(13):2733-45. PubMed ID: 19710634 [TBL] [Abstract][Full Text] [Related]
29. Chronic FAAH inhibition during nicotine abstinence alters habenular CB1 receptor activity and precipitates depressive-like behaviors. Simonnet A; Zamberletti E; Cador M; Rubino T; Caillé S Neuropharmacology; 2017 Feb; 113(Pt A):252-259. PubMed ID: 27737788 [TBL] [Abstract][Full Text] [Related]
30. Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats. Baranowska-Kuczko M; Kozłowska H; Kloza M; Karpińska O; Toczek M; Harasim E; Kasacka I; Malinowska B Life Sci; 2016 Apr; 151():288-299. PubMed ID: 26969765 [TBL] [Abstract][Full Text] [Related]
31. Effects of URB597 as an inhibitor of fatty acid amide hydrolase on WIN55, 212-2-induced learning and memory deficits in rats. Hasanein P; Teimuri Far M Pharmacol Biochem Behav; 2015 Apr; 131():130-5. PubMed ID: 25689415 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice. Nozaki C; Markert A; Zimmer A Eur Neuropsychopharmacol; 2015 Aug; 25(8):1388-96. PubMed ID: 25910421 [TBL] [Abstract][Full Text] [Related]
34. Increase of brain endocannabinoid anandamide levels by FAAH inhibition and alcohol abuse behaviours in the rat. Cippitelli A; Cannella N; Braconi S; Duranti A; Tontini A; Bilbao A; Defonseca FR; Piomelli D; Ciccocioppo R Psychopharmacology (Berl); 2008 Jul; 198(4):449-60. PubMed ID: 18446329 [TBL] [Abstract][Full Text] [Related]
35. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. Trezza V; Damsteegt R; Manduca A; Petrosino S; Van Kerkhof LW; Pasterkamp RJ; Zhou Y; Campolongo P; Cuomo V; Di Marzo V; Vanderschuren LJ J Neurosci; 2012 Oct; 32(43):14899-908. PubMed ID: 23100412 [TBL] [Abstract][Full Text] [Related]
36. Anxiety does not contribute to social withdrawal in the subchronic phencyclidine rat model of schizophrenia. Seillier A; Giuffrida A Behav Pharmacol; 2017 Oct; 28(7):512-520. PubMed ID: 28704273 [TBL] [Abstract][Full Text] [Related]
37. The great divide: Separation between in vitro and in vivo effects of PSNCBAM-based CB Gamage TF; Farquhar CE; Lefever TW; Thomas BF; Nguyen T; Zhang Y; Wiley JL Neuropharmacology; 2017 Oct; 125():365-375. PubMed ID: 28803965 [TBL] [Abstract][Full Text] [Related]
38. Differential effects of Δ9-tetrahydrocannabinol dosing on correlates of schizophrenia in the sub-chronic PCP rat model. Seillier A; Martinez AA; Giuffrida A PLoS One; 2020; 15(3):e0230238. PubMed ID: 32163506 [TBL] [Abstract][Full Text] [Related]
39. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels. Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871 [TBL] [Abstract][Full Text] [Related]
40. Role of endocannabinoid system in the ventral hippocampus of rats in the modulation of anxiety-like behaviours. Roohbakhsh A; Keshavarz S; Hasanein P; Rezvani ME; Moghaddam AH Basic Clin Pharmacol Toxicol; 2009 Nov; 105(5):333-8. PubMed ID: 19614892 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]